Search

RESEARCH

University College London | Professor Sasiwarang Goya Wannamethee

This is the next instalment of a vital four-decade study of heart health in British men. Despite the fact that we have an ageing population, the elderly have been under-represented in studies of heart and circulatory diseases. This means w...

Every five minutes, someone in the UK has a heart attack. We explain all you need to know about a heart attack including the causes, symptoms and effects.

RESEARCH

Queen Mary, University of London | Professor Dr Steffen Petersen

Osteoporosis is a condition resulting in weak and brittle bones that are more likely to break. It is common in the elderly, affecting over 3 million people in the UK, according to the National Osteoporosis Society. Heart disease and osteopo...

We are delighted to be partnering with the National Institute for Health and Care Research (NIHR) as they launch a consortium for a £50million challenge which seeks to address inequalities in cardiovascular disease (CVD).

Prevalence is the proportion of a particular population found to be affected by a medical condition - in this case a heart and circulatory disease such as coronary heart disease, or a risk factor such as high blood pressure.

RESEARCH

University of Oxford | Professor Fredrik Karpe

Obesity is a major risk factor for the development of cardiovascular disease. People who are overweight due to fat deposition around the abdomen (so-called ‘apple-shaped’ individuals) seem to have a higher risk of heart disease than those w...

Two molecules linked to increased stress levels play a key role in the development of Takotsubo syndrome, sometimes known as broken heart syndrome, according to research funded by us.

Specific antibodies could protect against heart attacks, according to a study we've funded published in the journal EBioMedicine.

Find out how we are committed to improving our practices to combat slavery and human trafficking.

A protein involved in the development of blood vessels in the womb could provide a promising target for new drugs to treat abdominal aortic aneurysms (AAAs), according to research funded by us published in the Journal of Clinical Investigation.